首页|含三氮唑吲哚类ATX/FXR双重调节剂的设计合成及生物活性初步评价

含三氮唑吲哚类ATX/FXR双重调节剂的设计合成及生物活性初步评价

扫码查看
目的 设计并合成结构新颖的含1,2,3-三氮唑片段的吲哚类化合物,并评价其对ATX酶抑制活性及FXR激动效应.方法 以ATX抑制剂LHR-144为先导化合物,整合FXR激动剂TERN-101结构中1-甲基吲哚片段,设计含1,2,3-三氮唑片段的吲哚类化合物;以5-硝基吲哚为起始原料,经甲基化、傅克酰基化、还原、叠氮化、1,3-偶极环加成、氯代、N-烃化、水解和Curtius重排9步反应得到目标化合物C1~C7;以1-(1-甲基-5-(4-氯甲基-1H-1,2,3-三氮唑-1-基)-1H-吲哚-3-基)-2,2,2-三氟乙基-1-酮(6)为原料,经N-烃化、水解、酯化、Curtius重排和水解反应得到目标化合物C8~C12.结果与结论 合成了 12个未见文献报道的含三氮唑吲哚类化合物,其结构经MS和NMR谱确证;大部分化合物显示出较强的ATX抑制活性和初步的FXR激动活性,其中化合物C8活性最为突出,其对ATX抑制活性的IC50值为1.32 nmol·L-1,对FXR激动活性的EC50值为0.67 µmol·L-1,具有进一步研究的价值.
Design,synthesis and preliminary evaluation of novel indole analogues bearing 1,2,3-triazole moiety as ATX/FXR dual regulators
Using previously reported ATX inhibitor LHR-144 and FXR agonist TERN-101 as the lead compounds,twelve indole-based compounds bearing 1,2,3-triazole moiety were designed as novel ATX/FXR dual regulators.With 5-nitroindole as the staring material,compounds C1-C7 were obtained through a sequential 9-step procedure including methylation,Friedel-Crafts acylation,reduction,azidation,1,3-dipolar cycloaddition,chlorination,N-alkylation,hydrolysis and Curtius rearrangement.Starting from intermediate 6,compounds C8-C12 were synthesized through N-alkylation,hydrolysis,esterification,Curtius rearrangement and hydrolysis reaction.The structures of target compounds were characterized by MS and NMR.The preliminary biological evaluation results showed that most compounds exerted strong ATX inhibitory potency,and compound C8 was the optimal compound with an IC50 value of 1.32 nmol·L-1.Meanwhile,compound C8 tended to serve as a modest FXR agonist with a primary EC50 value of 0.67 µmol·L-1,which was worthy of further study.

indole1,2,3-triazoledesignsynthesisATX/FXR dual regulators

姜语宸、郭梦娆、孙艺铭、高毓誉、马跃、刘燊、类红瑞、翟鑫

展开 >

沈阳药科大学基于靶点的药物设计与研究教育部重点实验室,辽宁沈阳 110016

吲哚 1,2,3-三氮唑 设计 合成 ATX/FXR双重调节剂

2024

中国药物化学杂志
沈阳药科大学,中国药学会

中国药物化学杂志

CSTPCD
影响因子:0.463
ISSN:1005-0108
年,卷(期):2024.34(6)